DrugPatentWatch Database Preview
FOSCAVIR Drug Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
When do Foscavir patents expire, and what generic alternatives are available?
Foscavir is a drug marketed by Clinigen Hlthcare and is included in one NDA.
The generic ingredient in FOSCAVIR is foscarnet sodium. There are seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the foscarnet sodium profile page.
Summary for FOSCAVIR
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 60 |
| Clinical Trials: | 7 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for FOSCAVIR |
| DailyMed Link: | FOSCAVIR at DailyMed |
Recent Clinical Trials for FOSCAVIR
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Johns Hopkins Bloomberg School of Public Health | Phase 2/Phase 3 |
| New Jersey Medical School | Phase 2/Phase 3 |
| University of South Florida | Phase 2/Phase 3 |
Pharmacology for FOSCAVIR
| Drug Class | Pyrophosphate Analog DNA Polymerase Inhibitor |
| Mechanism of Action | DNA Polymerase Inhibitors Chelating Activity |
US Patents and Regulatory Information for FOSCAVIR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Clinigen Hlthcare | FOSCAVIR | foscarnet sodium | INJECTABLE;INJECTION | 020068-001 | Sep 27, 1991 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for FOSCAVIR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Clinigen Hlthcare | FOSCAVIR | foscarnet sodium | INJECTABLE;INJECTION | 020068-001 | Sep 27, 1991 | Start Trial | Start Trial |
| Clinigen Hlthcare | FOSCAVIR | foscarnet sodium | INJECTABLE;INJECTION | 020068-001 | Sep 27, 1991 | Start Trial | Start Trial |
| Clinigen Hlthcare | FOSCAVIR | foscarnet sodium | INJECTABLE;INJECTION | 020068-001 | Sep 27, 1991 | Start Trial | Start Trial |
| Clinigen Hlthcare | FOSCAVIR | foscarnet sodium | INJECTABLE;INJECTION | 020068-001 | Sep 27, 1991 | Start Trial | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
